NCRx Pipeline Report 7.1.19

Erica Guetzlaff  •   July 1, 2019

National CooperativeRx constantly monitors the pharmaceutical pipeline. As treatment options change, it’s important to know which drugs bring the highest value. Our quarterly NCRx Pipeline Reports provide insight from our clinical team on what changes you can expect to see on the market and how they impact plan performance. Mayzent: Mayzent is the first treatment

Read More

NCRx Pipeline Report 5.1.19

Erica Guetzlaff  •   May 1, 2019

National CooperativeRx constantly monitors the pharmaceutical pipeline for the latest drugs to share with our members. As treatment options change, it’s important to know which drugs bring the highest value, and that’s where we come in with our new quarterly NCRx Pipeline Reports. Gain access to insight on market changes and how they may impact

Read More